AstraZeneca says advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective.
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/world/astrazeneca-oxford-trial-efficacy-1.5958717?cmp=rss.